147 related articles for article (PubMed ID: 24461378)
1. [Intensity-modulated radiotherapy in cervical cancer: towards a new standard?].
Mazeron R; Dumas I; El Khouri C; Lévy A; Attar M; Haie-Meder C
Cancer Radiother; 2014 Mar; 18(2):154-60; quiz 162, 164. PubMed ID: 24461378
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated whole pelvic radiotherapy provides effective dosimetric outcomes for cervical cancer treatment with lower toxicities.
Lv Y; Wang F; Yang L; Sun G
Cancer Radiother; 2014 Dec; 18(8):745-52. PubMed ID: 25451672
[TBL] [Abstract][Full Text] [Related]
3. [What technique for what tumor? Ethical and methodological issues: cervical cancer].
Barillot I
Cancer Radiother; 2014 Oct; 18(5-6):360-4. PubMed ID: 25179248
[TBL] [Abstract][Full Text] [Related]
4. [Intensity-modulated radiation therapy and stereotactic body radiation therapy for head and neck tumors: evidence-based medicine].
Lapierre A; Martin F; Lapeyre M
Cancer Radiother; 2014 Oct; 18(5-6):468-72. PubMed ID: 25155467
[TBL] [Abstract][Full Text] [Related]
5. [Modalities of breast cancer irradiation in 2016: Aims and indications of intensity modulated radiation therapy].
Bourgier C; Fenoglietto P; Lemanski C; Ducteil A; Charissoux M; Draghici R; Azria D
Cancer Radiother; 2016 Oct; 20(6-7):572-5. PubMed ID: 27614497
[TBL] [Abstract][Full Text] [Related]
6. [Evidence based medicine and high performance irradiation techniques: endometrial cancer].
Jouglar E; Barillot I
Cancer Radiother; 2014 Oct; 18(5-6):495-500. PubMed ID: 25155783
[TBL] [Abstract][Full Text] [Related]
7. CTV to PTV in cervical cancer: From static margins to adaptive radiotherapy.
Sun R; Mazeron R; Chargari C; Barillot I
Cancer Radiother; 2016 Oct; 20(6-7):622-8. PubMed ID: 27614513
[TBL] [Abstract][Full Text] [Related]
8. [Common chapter dedicated to taking care about the preparation of irradiation of head and neck carcinoma].
Maingon P; Giraud P; Pointreau Y
Cancer Radiother; 2016 Sep; 20 Suppl():S96-8. PubMed ID: 27521034
[TBL] [Abstract][Full Text] [Related]
9. [Radiotherapy for cervix carcinomas: clinical target volume delineation].
Gnep K; Mazeron R
Cancer Radiother; 2013 Oct; 17(5-6):486-92. PubMed ID: 23972469
[TBL] [Abstract][Full Text] [Related]
10. [Intensity-modulated radiotherapy for head and neck cancer. Dose constraint for salivary gland and mandible].
Pointreau Y; Lizée T; Bensadoun RJ; Boisselier P; Racadot S; Thariat J; Graff P
Cancer Radiother; 2016 Oct; 20(6-7):445-51. PubMed ID: 27614524
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer.
Mell LK; Tiryaki H; Ahn KH; Mundt AJ; Roeske JC; Aydogan B
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1504-10. PubMed ID: 18640499
[TBL] [Abstract][Full Text] [Related]
12. [Radiotherapy of hypopharynx cancers].
Pointreau Y; Lafond C; Trémolières P; Legouté F; Servagi-Vernat S; Giraud P; Maingon P; Calais G; Lapeyre M
Cancer Radiother; 2016 Sep; 20 Suppl():S126-30. PubMed ID: 27522185
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
Milby AB; Both S; Ingram M; Lin LL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
[TBL] [Abstract][Full Text] [Related]
14. [Radiotherapy of larynx cancers].
Pointreau Y; Lafond C; Legouté F; Trémolières P; Servagi-Vernat S; Giraud P; Maingon P; Calais G; Lapeyre M
Cancer Radiother; 2016 Sep; 20 Suppl():S131-5. PubMed ID: 27521037
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
Mell LK; Kochanski JD; Roeske JC; Haslam JJ; Mehta N; Yamada SD; Hurteau JA; Collins YC; Lengyel E; Mundt AJ
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1356-65. PubMed ID: 16757127
[TBL] [Abstract][Full Text] [Related]
16. [Locally advanced cervical cancer: Should intensity-modulated radiotherapy replace brachytherapy?].
Mazeron R; Gilmore J; Khodari W; Dumas I; Haie-Méder C
Cancer Radiother; 2011 Oct; 15(6-7):477-83. PubMed ID: 21880534
[TBL] [Abstract][Full Text] [Related]
17. [Radiotherapy for retroperitoneal sarcomas].
Sargos P; Stoeckle E; Henriques de Figueiredo B; Antoine M; Delannes M; Mervoyer A; Kantor G
Cancer Radiother; 2016 Oct; 20(6-7):677-84. PubMed ID: 27568294
[TBL] [Abstract][Full Text] [Related]
18. [Cervix carcinomas: place of intensity-modulated radiotherapy].
Barillot I
Cancer Radiother; 2009 Oct; 13(6-7):507-10. PubMed ID: 19695927
[TBL] [Abstract][Full Text] [Related]
19. [Intensity modulated radiation therapy for patients with gynecological malignancies after hysterectomy and chemotherapy/radiotherapy].
Chen ZY; Ma YB; Sheng XG; Zhang XL; Xue L; Song QQ; Liu NF; Miao HQ
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):305-8. PubMed ID: 17760262
[TBL] [Abstract][Full Text] [Related]
20. [Intensity-modulated radiotherapy of head and neck cancers. Dose constraint for spinal cord and brachial plexus].
Boisselier P; Racadot S; Thariat J; Graff P; Pointreau Y
Cancer Radiother; 2016 Oct; 20(6-7):459-66. PubMed ID: 27614529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
